Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 544-551

  Chauhan, Pradeep S ^a   Bhushan, Bharat ^a   Mishra, Ashwani K ^a   Singh, Laishram C ^a   Saluja, Sumita ^b   Verma, Saurabh ^a   Gupta, Dipendra K ^b   Mittal, Vishakha ^b   Chaudhry, Sumita ^b   Kapur, Sujala ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Acute myeloid leukemia; Cytogenetics; FLT3; Mutation

Indexed keywords

CD135 ANTIGEN; CD7 ANTIGEN; CYTARABINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CHILD; CLINICAL FEATURE; CONTINUOUS INFUSION; CYTOGENETICS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; FLOW CYTOMETRY; FMS-LIKE TYROSINE KINASE 3; HUMANS; IMMUNOPHENOTYPING; INFANT; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; YOUNG ADULT;

EID: 79960316841     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9485-4     Document Type: Article

References (38)

1. D Grimwade H Walker F Oliver K Wheatley C Harrison G Harrison J Rees I Hann R Stevens A Burnett A Goldstone 1998 The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 92 2322 2333 9746770 1:CAS:528:DyaK1cXmsVKnsrw%3D (Pubitemid 28452973)
2. ML Slovak KJ Kopecky PA Cassileth DH Harrington KS Theil A Mohamed E Paietta CL Willman DR Head JM Rowe SJ Forman FR Appelbaum 2000 Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study Blood 96 4075 4083 11110676 1:CAS:528:DC%2BD3cXosl2hsbo%3D
3. JC Byrd K Mrózek RK Dodge AJ Carroll CG Edwards DC Arthur MJ Pettenati SR Patil KW Rao MS Watson PR Koduru JO Moore RM Stone RJ Mayer EJ Feldman FR Davey CA Schiffer RA Larson CD Bloomfield 2002 Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 4325 4336 12393746 10.1182/blood-2002-03-0772 1:CAS:528:DC%2BD38XpsFCqs7o%3D (Pubitemid 35429670)
4. K Mrózek NA Heerema CD Bloomfield 2004 Cytogenetics in acute leukemia Blood Rev 18 115 136 15010150 10.1016/S0268-960X(03)00040-7 (Pubitemid 38380667)
5. O Rosnet D Stephenson MG Mattei S Marchetto M Shibuya VM Chapman D Birnbaum 1993 Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse Oncogene 8 173 179 8380915 1:CAS:528:DyaK3sXitVKmu7s%3D (Pubitemid 23047244)
6. F Birg O Rosnet N Carbuccia D Birnbaum 1994 The expression of FMS, KIT and FLT3 in hematopoietic malignancies Leuk Lymphoma 13 223 227 7519507 10.3109/10428199409056285 1:STN:280:DyaK2czisFyhug%3D%3D (Pubitemid 24141328)
7. M Nakao S Yokota T Iwai H Kaneko S Horiike K Kashima Y Sonoda T Fujimoto S Misawa 1996 Internal tandem duplication of the flt3 gene found in acute myeloid leukemia Leukemia 10 12 1911 1918 8946930 1:STN:280:DyaK2s7gt1Kqsg%3D%3D (Pubitemid 27019637)
8. H Kiyoi T Naoe Y Nakano S Yokota S Minami S Miyawaki N Asou K Kuriyama I Jinnai C Shimazaki H Akiyama K Saito H Oh T Motoji E Omoto H Saito R Ohno R Ueda 1999 Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia Blood 93 9 3074 3080 10216104 1:CAS:528:DyaK1MXivVyltbg%3D (Pubitemid 29200800)
9. WJ Rombouts I Blokland B Löwenberg RE Ploemacher 2000 Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene Leukemia 14 4 675 683 10764154 10.1038/sj.leu.2401731 1:CAS:528:DC%2BD3cXivFOhu70%3D (Pubitemid 30195459)
10. S Schnittger C Schoch M Dugas W Kern P Staib C Wuchter H Löffler CM Sauerland H Serve T Büchner T Haferlach W Hiddemann 2002 Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease Blood 100 1 59 66 12070009 10.1182/blood.V100.1.59 1:CAS:528:DC%2BD38XltF2rs7g%3D (Pubitemid 35177429)
11. C Thiede C Steudel B Mohr M Schaich U Schäkel U Platzbecker M Wermke M Bornhäuser M Ritter A Neubauer G Ehninger T Illmer 2002 Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis Blood 99 12 4326 4335 12036858 10.1182/blood.V99.12.4326 1:CAS:528:DC%2BD38XksFGlu7o%3D (Pubitemid 34627197)
12. S Meshinchi WG Woods DL Stirewalt DA Sweetser JD Buckley TK Tjoa ID Bernstein JP Radich 2001 Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia Blood 97 1 89 94 11133746 10.1182/blood.V97.1.89 1:CAS:528:DC%2BD3MXis1equg%3D%3D (Pubitemid 32061246)
13. DC Liang LY Shih IJ Hung CP Yang SH Chen TH Jaing HC Liu WH Chang 2002 Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia Cancer 94 12 3292 3298 12115363 10.1002/cncr.10598 1:CAS:528:DC%2BD38Xltlyjsrs%3D (Pubitemid 34670514)
14. F Hayakawa M TowatTanimoto M Kitamura Tari H Kiyoi H Saito T Naoe 2000 Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines Oncogene 19 5 624 631 10698507 10.1038/sj.onc.1203354 1:CAS:528:DC%2BD3cXhsVOgurY%3D (Pubitemid 30102913)
15. CD Baldus K Mrózek G Marcucci CD Bloomfield 2007 Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review Br J Haematol 137 5 387 400 17488484 10.1111/j.1365-2141.2007.06566.x 1:CAS:528:DC%2BD2sXotVOhu7c%3D (Pubitemid 46698282)
16. JA Pollard TA Alonzo RB Gerbing WG Woods BJ Lange DA Sweetser JP Radich ID Bernstein S Meshinchi 2006 FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia Blood 108 8 2764 2769 16809615 10.1182/blood-2006-04-012260 1:CAS:528:DC%2BD28XhtFWgtLzJ
17. M Mizuki R Fenski H Halfter I Matsumura R Schmidt C Müller W Grüning K Kratz-Albers S Serve C Steur T Büchner J Kienast Y Kanakura WE Berdel H Serve 2000 Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways Blood 96 12 3907 3914 11090077 1:CAS:528:DC%2BD3cXosVGnurs%3D
18. HG Drexler 1996 Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells Leukemia 10 588 599 8618433 1:STN:280:DyaK283gtV2qsA%3D%3D (Pubitemid 26144436)
19. FM Abu-Duhier AC Goodeve GA Wilson RS Care IR Peake JT Reilly 2001 Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia Br J Haematol 113 4 983 988 11442493 10.1046/j.1365-2141.2001.02850.x 1:CAS:528:DC%2BD3MXlslalsbg%3D (Pubitemid 32634768)
20. PD Kottaridis RE Gale ME Frew G Harrison SE Langabeer AA Belton H Walker K Wheatley DT Bowen AK Burnett AH Goldstone DC Linch 2001 The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Blood 98 6 1752 1759 11535508 10.1182/blood.V98.6.1752 1:CAS:528:DC%2BD3MXntFWgsbg%3D
21. SP Whitman KJ Archer L Feng C Baldus B Becknell BD Carlson AJ Carroll K Mrózek JW Vardiman SL George JE Kolitz RA Larson CD Bloomfield MA Caligiuri 2001 Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study Cancer Res 61 19 7233 7239 11585760 1:CAS:528:DC%2BD3MXnsVeht7c%3D (Pubitemid 32946520)
22. Y Mori G Yoshimoto T Kumano T Miyamoto T Iino K Takenaka H Iwasaki N Harada N Kinukawa K Nagafuji T Teshima K Shimoda K Akashi M Harada 2007 Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation Eur J Haematol 79 1 17 24 17598835 10.1111/j.1600-0609.2007.00866.x 1:CAS:528:DC%2BD2sXot1KlsLk%3D (Pubitemid 47000615)
23. V Rausei-Mills KL Chang KK Gaal LM Weiss Q Huang 2008 Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation Am J Clin Pathol 129 4 624 629 18343790 10.1309/NRTX9AKXHR5JBT93 1:CAS:528:DC%2BD1cXkvVeit78%3D (Pubitemid 352029282)
24. B Bhushan D Ahuja S Verma S Saluja S Siddiqui S Kapur 2007 Relation of cell viability and apoptosis with clinical remission following induction chemotherapy in ALL and AML J Exp Clin Cancer Res 26 3 313 321 17987789 1:CAS:528:DC%2BD2sXhtlSlur7M (Pubitemid 47584804)
25. Y Yamamoto H Kiyoi Y Nakano R Suzuki Y Kodera S Miyawaki N Asou K Kuriyama F Yagasaki C Shimazaki H Akiyama K Saito M Nishimura T Motoji K Shinagawa A Takeshita H Saito R Ueda R Ohno T Naoe 2001 Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies Blood 97 8 2434 2439 11290608 10.1182/blood.V97.8.2434 1:CAS:528:DC%2BD3MXivFOgtbk%3D (Pubitemid 32291491)
26. RF Schlenk K Döhner J Krauter S Fröhling A Corbacioglu L Bullinger M Habdank D Späth M Morgan A Benner B Schlegelberger G Heil A Ganser H Döhner 2008 German-Austrian Acute Myeloid Leukemia Study Group. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia N Engl J Med 358 18 1909 1918 18450602 10.1056/NEJMoa074306 1:CAS:528:DC%2BD1cXlt1Ggu70%3D (Pubitemid 351620111)
27. K Mrózek G Marcucci P Paschka SP Whitman CD Bloomfield 2007 Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109 2 431 448 16960150 10.1182/blood-2006-06-001149 (Pubitemid 46105936)
28. L Wang D Lin X Zhang S Chen M Wang J Wang 2005 Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients Leuk Res 29 12 1393 1398 15996732 10.1016/j.leukres.2005.05.013 1:CAS:528: DC%2BD2MXhtFOmsLbK (Pubitemid 41562241)
29. N Colovic N Tosic S Aveic M Djuric N Milic V Bumbasirevic M Colovic S Pavlovic 2007 Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia Ann Hematol 86 10 741 747 17579862 10.1007/s00277-007-0325-3 (Pubitemid 47337937)
30. U Bacher C Haferlach W Kern T Haferlach S Schnittger 2008 Prognostic relevance of FLT3-TKD mutations in AML: the combination matters-an analysis of 3082 patients Blood 111 5 2527 2537 17965322 10.1182/blood-2007-05-091215 1:CAS:528:DC%2BD1cXivFaktrc%3D
31. A Andersson B Johansson C Lassen F Mitelman R Billström T Fioretos 2004 Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients Eur J Haematol 72 5 307 313 15059064 10.1111/j.1600-0609.2004.00225.x 1:CAS:528: DC%2BD2cXkt1Kgu74%3D (Pubitemid 38520727)
32. T Iwai S Yokota M Nakao T Okamoto M Taniwaki N Onodera A Watanabe A Kikuta A Tanaka K Asami I Sekine H Mugishima Y Nishimura S Koizumi Y Horikoshi J Mimaya S Ohta K Nishikawa A Iwai T Shimokawa M Nakayama K Kawakami T Gushiken N Hyakuna T Fujimoto 1999 Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan Leukemia 13 1 38 43 10049058 10.1038/sj.leu.2401241 1:CAS:528:DyaK1MXht1GnurY%3D (Pubitemid 29043715)
33. S Meshinchi DL Stirewalt TA Alonzo TJ Boggon RB Gerbing JL Rocnik BJ Lange DG Gilliland JP Radich 2008 Structural and numerical variation of FLT3/ITD in pediatric AML Blood 111 10 4930 4933 18305215 10.1182/blood-2008-01-117770 1:CAS:528:DC%2BD1cXmtlaiurg%3D
34. CM Zwaan S Meshinchi JP Radich AJ Veerman DR Huismans L Munske M Podleschny K Hählen R Pieters M Zimmermann D Reinhardt J Harbott U Creutzig GJ Kaspers F Griesinger 2003 FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance Blood 102 7 2387 2394 12816873 10.1182/blood-2002-12-3627 1:CAS:528:DC%2BD3sXnslykt7c%3D (Pubitemid 37193574)
35. S Meshinchi WG Woods DL Stirewalt DA Sweetser JD Buckley TK Tjoa ID Bernstein JP Radich 2001 Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia Blood 97 1 89 94 11133746 10.1182/blood.V97.1.89 1:CAS:528:DC%2BD3MXis1equg%3D%3D (Pubitemid 32061246)
36. S Frohling RF Schlenk J Breitruck A Benner S Kreitmeier K Tobis H Dohner K Dohner 2002 Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm Blood 100 4372 4380 12393388 10.1182/blood-2002-05-1440 1:CAS:528:DC%2BD38XpsFCqsL4%3D (Pubitemid 35434129)
37. I Moreno G Martín P Bolufer E Barragán E Rueda J Román P Fernández P León A Mena J Cervera A Torres MA Sanz 2003 Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia Haematologica 88 1 19 24 12551822 1:CAS:528:DC%2BD3sXitVyru78%3D (Pubitemid 36168850)
38. L Muñoz A Aventín N Villamor J Juncà G Acebedo A Domingo M Rozman JP Torres M Tormo JF Nomdedéu 2003 Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication Hematologica 88 6 635 637